|
[Related PubMed/MEDLINE]
Total Number of Papers: 5175
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: H. pylori |
| Long Form |
: Helicobacter pylori |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
A Bibliometric Analysis of Atrophic Gastritis From 2011 to 2021. |
AG, GC, SPEM |
| 2 |
2022 |
A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates. |
--- |
| 3 |
2022 |
A novel rapid and accurate method for detecting Helicobacter Pylori: the modified antigen test. |
ROC |
| 4 |
2022 |
A prospective study on Helicobacter pylori rapid urease test false negativity: is it time for its use in restricted situations? |
DOB, RUT, UBT |
| 5 |
2022 |
Advanced gastric cancer detected during regular follow-up after eradication of Helicobacter pylori. |
--- |
| 6 |
2022 |
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication. |
SCFAs, VPZ |
| 7 |
2022 |
An Overview of Autophagy in Helicobacter pylori Infection and Related Gastric Cancer. |
--- |
| 8 |
2022 |
An Unusual Cause of Refractory Hypothyroidism. |
TSH |
| 9 |
2022 |
An Unusual Cause of Secondary ITP in a 34-Year-Old Hispanic Male. |
ITP |
| 10 |
2022 |
An Updated Meta-Analysis of the Relationship Between Helicobacter pylori Infection and the Risk of Coronary Heart Disease. |
CHD, OR |
| 11 |
2022 |
Antibacterial Effects of Bacteriocin PLNC8 against Helicobacter pylori and Its Potential Mechanism of Action. |
MIC, SEM, TEM |
| 12 |
2022 |
Antibiotic Resistance of Helicobacter pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam. |
AMX, CLR, LEV, MTZ, TET |
| 13 |
2022 |
Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China. |
--- |
| 14 |
2022 |
Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria. |
Eb, EPS, Fu, LA |
| 15 |
2022 |
Antisense long non-coding RNAs in gastric cancer. |
lncRNAs |
| 16 |
2022 |
Application of traditional Chinese medicine in treatment of Helicobacter pylori infection. |
TCM |
| 17 |
2022 |
Aspirin Use Is Not Associated with the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection. |
EGC, HR, MGC |
| 18 |
2022 |
Assessing the Synergistic Activity of Clarithromycin and Therapeutic Oils Encapsulated in Sodium Alginate Based Floating Microbeads. |
DSC, E. coli, FTIR, HPMC, S. aureus, SEM, TGA |
| 19 |
2022 |
Assessment of first-line eradication treatment in Greece: data from the European Registry on Helicobacter pylori management (Hp-EuReg). |
mITT, PPIs |
| 20 |
2022 |
Association between dental caries and Helicobacter pylori infection in Japanese adults: A cross-sectional study. |
--- |
| 21 |
2022 |
Association Between H. pylori Infection and Colorectal Polyps: A Meta-Analysis of Observational Studies. |
OR |
| 22 |
2022 |
Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis. |
GC, ORs |
| 23 |
2022 |
Association between Helicobacter pylori infection and growth outcomes in children: A meta-analysis. |
HAZ, ORs, SMDs |
| 24 |
2022 |
Association Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China. |
FAP, LSM, NAFLD, TE |
| 25 |
2022 |
Association between serum vitamin D levels and Helicobacter pylori cytotoxic-associated gene A seropositivity: a cross-sectional study in US adults from NHANES III. |
CagA, VD |
| 26 |
2022 |
Association between ulcerative colitis and Helicobacter pylori infection: A case-control study. |
CI, HpSA, IBD, OR, UC |
| 27 |
2022 |
Association of Helicobacter pylori infection with osteoporosis risk in a physical examination population. |
BMD, OR |
| 28 |
2022 |
Association of hypertension with helicobacter pylori: A systematic review and meta‑analysis. |
--- |
| 29 |
2022 |
Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers. |
AG, AUC, CON, FC, GC, miRNAs, NGS |
| 30 |
2022 |
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. |
AIG |
| 31 |
2022 |
Automated Disease Detection in Gastroscopy Videos Using Convolutional Neural Networks. |
CNN |
| 32 |
2022 |
Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases. |
GC, SAR |
| 33 |
2022 |
Biochemical and Kinetic Characterization of the Glucose-6-Phosphate Dehydrogenase from Helicobacter pylori Strain 29CaP. |
GdnHCl, HpG6PD |
| 34 |
2022 |
Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention. |
FBCM, ICER, QALY |
| 35 |
2022 |
Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort. |
aOR, MMP-10 |
| 36 |
2022 |
CagA+ Helicobacter pylori, Not CagA- Helicobacter pylori, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation. |
--- |
| 37 |
2022 |
Capsaicin Inhibits Inflammation and Gastric Damage during H pylori Infection by Targeting NF-kB-miRNA Axis. |
--- |
| 38 |
2022 |
Changes in Helicobacter pylori Treatment from Discovery to Nowadays: A High-Level Analysis of PubMed Publications. |
--- |
| 39 |
2022 |
CircMAN1A2 is upregulated by Helicobacter pylori and promotes development of gastric cancer. |
--- |
| 40 |
2022 |
Clinical aspects of Helicobacter heilmannii-associated gastritis in patients with dyspepsia: A systematic review and meta-analysis. |
H. heilmannii |
| 41 |
2022 |
Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia. |
LGIN, RFA |
| 42 |
2022 |
Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori. |
BLEIA, IC |
| 43 |
2022 |
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis. |
--- |
| 44 |
2022 |
Clinicopathological characteristics of pancreatic acinar cell metaplasia associated with Helicobacter pylori infection. |
CHI, NHI, PACM, USS |
| 45 |
2022 |
Clinicopathological Features of Gastric Cancer with Autoimmune Gastritis. |
AIG, APCA |
| 46 |
2022 |
Coinfection of Helicobacter pylori and Hepatitis C Virus in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. |
CI, HBV, HCC, HCV, OR |
| 47 |
2022 |
Collagenous gastroduodenocolitis in a Korean adolescent: first pediatric case report in Asia. |
CC, CD, CG, CGDC, CLO, EGD |
| 48 |
2022 |
Combined antrum and corpus biopsy protocol improves Helicobacter pylori culture success. |
AST |
| 49 |
2022 |
Comment on Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics 2022, 12, 133. |
IHC |
| 50 |
2022 |
Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland. |
BQT, L-TT, M-TT, PPI |
| 51 |
2022 |
Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial. |
--- |
| 52 |
2022 |
Comparison of special stains (Giemsa stain and Modified Toluidine Blue stain) with immunohistochemistry as gold standard for the detection of H. pylori in gastric biopsies. |
IHC, MTB |
| 53 |
2022 |
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori. |
IA, IAFB |
| 54 |
2022 |
Cordycepin exhibits anti-bacterial and anti-inflammatory effects against gastritis in Helicobacter pylori-infected mice. |
--- |
| 55 |
2022 |
Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections. |
ITT, PCR, PP, WGS |
| 56 |
2022 |
Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. |
EBV, GC |
| 57 |
2022 |
Could microbiome analysis be a new diagnostic tool in gastric carcinogenesis for high risk, Helicobacter pylori negative patients? |
--- |
| 58 |
2022 |
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review. |
--- |
| 59 |
2022 |
Curative resection with endoscopic submucosal dissection of early gastric cancer in Helicobacter pylori-negative Ménétrier's disease: A case report. |
ESD, UGI |
| 60 |
2022 |
DEC1 promotes progression of Helicobacter pylori-positive gastric cancer by regulating Akt/NF-κB pathway. |
DEC1, GC |
| 61 |
2022 |
Delayed hemorrhagic gastritis caused by immunotherapy in a patient With metastatic melanoma. |
CMV, EGD, GI |
| 62 |
2022 |
Dental risk factors associated with oral Helicobacter pylori infection: a cross-sectional study based on saliva antigen test. |
--- |
| 63 |
2022 |
Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma. |
EF, GLA, GMZL, IF, ILROG, ISRT, MALT, RT |
| 64 |
2022 |
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study. |
--- |
| 65 |
2022 |
Diagnostic approach to Helicobacter pylori-related gastric oncogenesis. |
--- |
| 66 |
2022 |
Differences in community structure of gastrointestinal tract between Helicobacter pylori positive patients and negative patients with gastric cancer. |
--- |
| 67 |
2022 |
Different Metabolites of the Gastric Mucosa between Patients with Current Helicobacter pylori Infection, Past Infection, and No Infection History. |
GC-TOF-MS, RAs |
| 68 |
2022 |
Distribution characteristics of the sabA, hofC, homA, homB and frpB-4 genes of Helicobacter pylori in different regions of China. |
OMPs, PCR |
| 69 |
2022 |
Does technology-enhanced communication improve Helicobacter pylori eradication outcomes?-A meta-analysis. |
TEC |
| 70 |
2022 |
E-Cadherin Orthologues as Substrates for the Serine Protease High Temperature Requirement A (HtrA). |
HtrA |
| 71 |
2022 |
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis. |
LYs, NSAIDs, QALYs |
| 72 |
2022 |
Effect and Safety of Helicobacter pylori Eradication Treatment Based on Molecular Pathologic Antibiotic Resistance in Chinese Elderly People. |
AMX, CIs, CLR, ERs, FLQ, ITT, PP, TET |
| 73 |
2022 |
Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials. |
CI, EPI, RCTs, RR, TSA |
| 74 |
2022 |
Effect of Helicobacter Pylori Eradication on Human Gastric Microbiota: A Systematic Review and Meta-Analysis. |
--- |
| 75 |
2022 |
Effect of Helicobacter pylori infection on the first-line treatment outcomes in patients with immune thrombocytopenic purpura. |
ITP |
| 76 |
2022 |
Effect of Probiotic-Assisted Eradication of cagA+/vacA s1m1 Helicobacter pylori on Intestinal Flora. |
BQT, CagA, IL-8, TNF-alpha, VacA |
| 77 |
2022 |
Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials. |
CI, PPI, RR, VPZ |
| 78 |
2022 |
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta-analysis. |
EPE, RCTs, RR |
| 79 |
2022 |
Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. |
GC |
| 80 |
2022 |
Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials. |
ITT, P-CABs, PP, PPIs, RCTs |
| 81 |
2022 |
Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication. |
ITT, RCT |
| 82 |
2022 |
Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children. |
--- |
| 83 |
2022 |
Eighteen-year-old man with syncope with Helicobacter pylori as the culprit: a case report. |
GI, PPI, PUD |
| 84 |
2022 |
Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam. |
AmoxR, AmoxS, MIC |
| 85 |
2022 |
Emerging Role of Helicobacter pylori in the Immune Evasion Mechanism of Gastric Cancer: An Insight Into Tumor Microenvironment-Pathogen Interaction. |
CAFs, MDSCs, MSCs, NK, TAMs, TME |
| 86 |
2022 |
Emphasizing the importance of successful eradication of Helicobacter pylori on initial treatment. |
--- |
| 87 |
2022 |
Empiric "Three-in-One" Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. |
BQT, CI, ITT, PP, PPI |
| 88 |
2022 |
Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods? |
PPI |
| 89 |
2022 |
Endoscopic and histopathological findings in adult dyspeptic patients, and their association with Helicobacter pylori infection in Dhaka, Bangladesh. |
BSMMU, DMCH, RUT |
| 90 |
2022 |
Eosinophilic Duodenal Ulcer Exacerbation after Helicobacter pylori Eradication in a 14-Year-Old Boy. |
EGIDs, IL-5 |
| 91 |
2022 |
Epidemiological study of Helicobacter pylori infection and its association with gastric carcinogenesis. |
--- |
| 92 |
2022 |
Epidemiological, clinical, and histological presentation of celiac disease in Northwest China. |
CD, GI, IgA, tTG |
| 93 |
2022 |
Epidemiology of Helicobacter pylori in Australia: a scoping review. |
--- |
| 94 |
2022 |
Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. |
DBP, HDL, HPN, LDL, MPV, TP |
| 95 |
2022 |
Evaluating the MicroRNA Expression of IL-35 and IL-37 in Helicobacter Pylori-infected Patients with Gastritis and Gastric Ulcer. |
IL |
| 96 |
2022 |
Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations. |
13C-UBT |
| 97 |
2022 |
Evaluation of hematological parameters in dyspepsia patients infected with Helicobacter pylori: A retrospective study from the Central Region of Saudi Arabia. |
KSA |
| 98 |
2022 |
Evaluation of the Gastric Microbiome in Patients with Chronic Superficial Gastritis and Intestinal Metaplasia. |
CSG, IM |
| 99 |
2022 |
Everolimus ameliorates Helicobacter pylori infection-induced inflammation in gastric epithelial cells. |
CXCL1, ICAM-1, IL, MCP-1, MDA, mTOR, ROS, TNF-alpha |
| 100 |
2022 |
Evolving Autoimmune Gastritis Initially Hidden by Active Helicobacter pylori Gastritis. |
AIG, ECL |
|
A Search Service for Abbreviation / Long Form
